Atara Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATRA and other ETFs, options, and stocks.About ATRA
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need.
CEOAnhco Nguyen
CEOAnhco Nguyen
Employees153
Employees153
HeadquartersThousand Oaks, California
HeadquartersThousand Oaks, California
Founded2012
Founded2012
Employees153
Employees153
ATRA Key Statistics
Market cap124.67M
Market cap124.67M
Price-Earnings ratio8.02
Price-Earnings ratio8.02
Dividend yield—
Dividend yield—
Average volume84.37K
Average volume84.37K
High today$18.15
High today$18.15
Low today$16.70
Low today$16.70
Open price$17.70
Open price$17.70
Volume59.42K
Volume59.42K
52 Week high$18.71
52 Week high$18.71
52 Week low$5.01
52 Week low$5.01
Stock Snapshot
The current Atara Biotherapeutics(ATRA) stock price is $17.97, with a market capitalization of 124.67M. The stock trades at a price-to-earnings (P/E) ratio of 8.02.
On 2025-12-17, Atara Biotherapeutics(ATRA) stock moved within a range of $16.70 to $18.15. With shares now at $17.97, the stock is trading +7.6% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 59.42K, compared to an average daily volume of 84.37K.
Over the past 52 weeks, Atara Biotherapeutics(ATRA) stock has traded between a high of $18.71 and a low of $5.01.
Over the past 52 weeks, Atara Biotherapeutics(ATRA) stock has traded between a high of $18.71 and a low of $5.01.
People also own
Based on the portfolios of people who own ATRA. This list is generated using Robinhood data, and it’s not a recommendation.